Roivant Sciences Ltd.
- Last sale
- Nov 12, 2026 · -4.49%
- Market cap
- $28.96B
- 724.56M shares
- Filings
- 1,015
Q2 2026−71.6% FY25 yoy
Q2 2026N/M FY25 yoy
Q2 2026N/M FY25 yoy
Q2 2026derivedN/M FY25 yoy
Q2 2026N/M FY25 yoy
Q2 2026−47.7% FY25 yoy
- $28.96B
- —
- 704.9×
- 7.2×
- -0.12%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2026-03-31 | $8,260,000 | reported | |
| FY 2024 | 2025-03-31 | $29,053,000 | reported | |
| FY 2023 | 2024-03-31 | $32,713,000 revised | reported | |
| FY 2022 | 2023-03-31 | $31,530,000 revised | reported | |
| FY 2021 | 2021-03-31 | $23,795,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2024 | — | $1.29B | $1.29B | — | 679.81M sh | −8.0% | — |
| FY2023 | — | $0.00 | $0.00 | — | 738.72M sh | −2.8% | — |
| FY2022 | — | $0.00 | $0.00 | — | 760.14M sh | +9.4% | — |
Segments
Products
LineFY2023ShareChange
Product revenue, net$75.06M229%+168.0%
License, milestone and other revenue$49.74M152%+49.5%
Total$32.71M
Pharmaceutical preparations
Roivant Sciences Ltd. is the 175th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
ISCOInternational Stem Cell CORP$9.1M0.2%4.6%$2.6MBIOABioAge Labs, Inc.$9.0M—896.1%$260.1M
ROIVRoivant Sciences Ltd. (this company)$8.3M71.6%3,629.2%$29.0B
COYACoya Therapeutics, Inc.$7.9M123.6%267.1%$75.8MACRSAclaris Therapeutics, Inc.$7.8M58.2%829.6%$635.2MBOLTBolt Biotherapeutics, Inc.$7.7M0.1%433.7%$12.6MADAGAdagene Inc.$7.7M7,332.8%229.6%—XENEXenon Pharmaceuticals Inc.$7.5M—4,612.1%$4.0BOVIDOvid Therapeutics Inc.$7.3M1,181.3%240.1%$479.4MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Roivant Sciences Ltd. · CIK 1635088 · Engraved from SEC EDGAR